Phase I/II trial of reovirus and gemcitabine in patients with metastatic solid tumours.

Trial Profile

Phase I/II trial of reovirus and gemcitabine in patients with metastatic solid tumours.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 13 Apr 2011

At a glance

  • Drugs Gemcitabine; Pelareorep
  • Indications Lung cancer; Ovarian cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Apr 2011 Status changed from active, no longer recruiting to completed.
    • 01 Jun 2009 Interim results presented at the American Society of Clinical Oncology (ASCO) 2009 annual meeting, according to an Oncolytics Biotech media release.
    • 25 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by Oncolytics Biotech.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top